Caribou Biosciences (CRBU) Change in Cash (2020 - 2026)
Caribou Biosciences' (CRBU) quarterly Change in Cash came in at -$303000.0 in Q1 2026, down 102.31% year-on-year from $13.1 million in Q1 2025, and down 124.92% on a QoQ basis from $1.2 million in Q4 2025.
Caribou Biosciences (CRBU) Change in Cash (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has 7 years of Change in Cash data on file, last reported at -$303000.0 in Q1 2026.
- On a quarterly basis, Change in Cash fell 102.31% year-over-year to -$303000.0 in Q1 2026; TTM through Mar 2026 was -$17.4 million, a 13.13% increase from a year earlier, with the FY2025 full-year figure at -$3.9 million, up 88.72% from the prior year.
- Change in Cash for Q1 2026 stood at -$303000.0, down from $1.2 million in the prior quarter.
- Over the last five years, Change in Cash for CRBU reached as high as $37.9 million in Q3 2023 and fell as low as -$92.8 million in Q1 2022.
- Historically, Change in Cash has averaged -$13.4 million across 5 years, with a median of -$5.9 million in 2024.
- Across the five-year window, Change in Cash sank 185.75% in 2024 and soared 844.84% in 2025, its largest moves.
- Year by year, Change in Cash stood at -$23.7 million in 2022, then plunged by 122.75% to -$52.9 million in 2023, then jumped by 70.36% to -$15.7 million in 2024, then soared by 107.76% to $1.2 million in 2025, then slumped by 124.92% to -$303000.0 in 2026.
- Per Business Quant data, the three most recent Change in Cash figures were -$303000.0 in Q1 2026, $1.2 million in Q4 2025, and -$14.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Caribou Biosciences | 156.25 Mn | 38.63 Mn | - | -303,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -303,000.00 |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | -14.06 Mn |
| Jun 30, 2025 | -4.22 Mn |
| Mar 31, 2025 | 13.12 Mn |
| Dec 31, 2024 | -15.68 Mn |
| Sep 30, 2024 | -5.90 Mn |
| Jun 30, 2024 | -11.53 Mn |
| Mar 31, 2024 | -1.76 Mn |
| Dec 31, 2023 | -52.90 Mn |
| Sep 30, 2023 | 37.86 Mn |
| Jun 30, 2023 | 13.45 Mn |
| Mar 31, 2023 | -5.59 Mn |
| Dec 31, 2022 | -23.75 Mn |
| Sep 30, 2022 | -30.06 Mn |
| Jun 30, 2022 | -35.48 Mn |
| Mar 31, 2022 | -92.79 Mn |
| Dec 31, 2021 | -194.89 Mn |
| Sep 30, 2021 | 305.79 Mn |
| Jun 30, 2021 | -16.35 Mn |